Determining molecular phenotypes of metastatic breast cancer that respond to the small molecule inhibitor of ErbB1 and ErbB2, lapatinib (GW572016)
Publication
, Conference
Blackwell, KL; Kaplan, EH; Franco, SX; Marcom, PK; Maleski, JE; Spector, NL; Stocum, MT; Sorensen, MJ; Berger, MS
Published in: BREAST CANCER RESEARCH AND TREATMENT
January 1, 2004
Duke Scholars
Published In
BREAST CANCER RESEARCH AND TREATMENT
ISSN
0167-6806
Publication Date
January 1, 2004
Volume
88
Start / End Page
S30 / S30
Location
San Antonio, TX
Publisher
SPRINGER
Conference Name
27th Annual Charles A Colman San Antonio Breast Cancer Symposium
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Blackwell, K. L., Kaplan, E. H., Franco, S. X., Marcom, P. K., Maleski, J. E., Spector, N. L., … Berger, M. S. (2004). Determining molecular phenotypes of metastatic breast cancer that respond to the small molecule inhibitor of ErbB1 and ErbB2, lapatinib (GW572016). In BREAST CANCER RESEARCH AND TREATMENT (Vol. 88, pp. S30–S30). San Antonio, TX: SPRINGER.
Blackwell, K. L., E. H. Kaplan, S. X. Franco, P. K. Marcom, J. E. Maleski, N. L. Spector, M. T. Stocum, M. J. Sorensen, and M. S. Berger. “Determining molecular phenotypes of metastatic breast cancer that respond to the small molecule inhibitor of ErbB1 and ErbB2, lapatinib (GW572016).” In BREAST CANCER RESEARCH AND TREATMENT, 88:S30–S30. SPRINGER, 2004.
Blackwell KL, Kaplan EH, Franco SX, Marcom PK, Maleski JE, Spector NL, et al. Determining molecular phenotypes of metastatic breast cancer that respond to the small molecule inhibitor of ErbB1 and ErbB2, lapatinib (GW572016). In: BREAST CANCER RESEARCH AND TREATMENT. SPRINGER; 2004. p. S30–S30.
Blackwell, K. L., et al. “Determining molecular phenotypes of metastatic breast cancer that respond to the small molecule inhibitor of ErbB1 and ErbB2, lapatinib (GW572016).” BREAST CANCER RESEARCH AND TREATMENT, vol. 88, SPRINGER, 2004, pp. S30–S30.
Blackwell KL, Kaplan EH, Franco SX, Marcom PK, Maleski JE, Spector NL, Stocum MT, Sorensen MJ, Berger MS. Determining molecular phenotypes of metastatic breast cancer that respond to the small molecule inhibitor of ErbB1 and ErbB2, lapatinib (GW572016). BREAST CANCER RESEARCH AND TREATMENT. SPRINGER; 2004. p. S30–S30.
Published In
BREAST CANCER RESEARCH AND TREATMENT
ISSN
0167-6806
Publication Date
January 1, 2004
Volume
88
Start / End Page
S30 / S30
Location
San Antonio, TX
Publisher
SPRINGER
Conference Name
27th Annual Charles A Colman San Antonio Breast Cancer Symposium
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences